Form 4: Nuvation Bio Executive Acquires Shares and Stock Options
SEC Form 4
David C. Hanley, Chief Technical Operations Officer at Nuvation Bio, reports acquisition of shares and stock options.
Summary
- David C. Hanley, Chief Technical Operations Officer of Nuvation Bio Inc. [NUVB], filed a Form 4.
- The filing reports a transaction on February 28, 2025, where Hanley acquired stock options for 500,000 shares of Class A Common Stock at an exercise price of $1.97.
- The options vest as to 25% on the one-year anniversary of February 28, 2025, and then monthly over the following 36 months, contingent upon continuous service.
- Hanley also reported owning 18,000 shares of Class A Common Stock.
- This includes 3,000 shares acquired on May 17, 2024, and 3,000 shares acquired on November 19, 2024, under the Issuer's 2021 Employee Stock Purchase Plan.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of options could be seen as a slightly positive indicator of executive confidence, but it's not definitively bullish.
Positives
- The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedule of the stock options suggests a long-term commitment from the executive to the company's success.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The stock option grant could potentially align the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 2024-05-17 | 3,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. |
| 2024-11-19 | 3,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. |
| 2025-02-28 | Date of stock option grant and first vesting date (25% of options). |
| 2025-02-28 | Date of earliest transaction. |
| 2035-02-27 | Expiration date of the stock options. |
| 2025-03-04 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.